<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04156503</url>
  </required_header>
  <id_info>
    <org_study_id>PD222/17</org_study_id>
    <nct_id>NCT04156503</nct_id>
  </id_info>
  <brief_title>Pilot Study-Quantitative Analysis of Positional Fatty Acids in Postprandial Chylomicron Triacylglycerol Using 13C NMR Spectroscopy</brief_title>
  <official_title>A Pilot Study for the Quantitative Analysis of Positional Fatty Acids in Postprandial Chylomicron Triacylglycerol Using 13C NMR Spectroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Malaysia Palm Oil Board</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Malaysia Palm Oil Board</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      13C NMR spectroscopy has been validated to be a rapid, direct and accurate quantitative&#xD;
      method in determination of positional distribution of fatty acids in edible oils and fats,&#xD;
      including the palm oil fractions (from soft olein to hard stearin). Nevertheless, there is&#xD;
      paucity of literature describing its application in determining the positional fatty acid&#xD;
      composition in blood triacylglycerols &amp; biological samples, despite its widely used&#xD;
      application in edible oils and fats. The postprandial feeding intervention is aimed to&#xD;
      harvest chylomicron rich in triglycerides (~97% TAG) for NMR analysis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A pilot postprandial study with double blind, 2x2 arms randomized crossover experimental&#xD;
      design will be carried out. A total of 10 subjects (5 males, 5 females) will be recruited and&#xD;
      divided into 2 groups. Each group will be assigned to one of the test fat and fed with test&#xD;
      meal prepared with 50g of test fats. 10 mL of blood samples will be collected at time points&#xD;
      0 (baseline, before meal) and 3, 4 and 5h after finish the meal. There shall be a 2-weeks&#xD;
      washout period between each test fat.&#xD;
&#xD;
      Test fats used for this study are palm olein, with predominantly oleic acid at sn-2 position&#xD;
      of the triglyceride backbone (about 68%, Gunstone et al, 2007) and lard, with predominantly&#xD;
      palmitic acid at sn-2 position (about 72%, Gunstone et al., 2007). A high fat muffin with 50g&#xD;
      of test fat will be formulated using the above two test fats mentioned. On each study day, a&#xD;
      high fat muffin will be served and a glass of skim milk will be provided for subjects to help&#xD;
      the digestion of fats from the muffins.&#xD;
&#xD;
      Chylomicron will be harvested using the ultracentrifugation technique. Samples collected will&#xD;
      be stored in -80Â°C prior to NMR analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 18, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">December 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Triglycerides profile in chylomicron harvested</measure>
    <time_frame>Up to hour 5</time_frame>
    <description>the positional composition of fatty acid in test fat that are retained upon absorption ( samples are pooled from 3, 4 &amp;5 hour after test diet)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Test fat: Palm olein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One high fat muffin will be serves together with a glass of low fat milk shake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test fat: Lard</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One high fat muffin will be serves together with a glass of low fat milk shake.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Palm olein vs Lard</intervention_name>
    <description>A 5-hour postprandial feeding intervention with 2-weeks washout in between. Blood samples will be collected at hour 0 (baseline) before test meal, and hour 3, 4 and 5 after consumption of test meal.</description>
    <arm_group_label>Test fat: Lard</arm_group_label>
    <arm_group_label>Test fat: Palm olein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Non muslim, aged between 25 - 40 yrs old.&#xD;
&#xD;
          -  BMI between 20 - 27.5 kg/m2.&#xD;
&#xD;
          -  Blood pressure with &lt;130mmHg for systolic pressure and &lt; 80 mmHg for diastolic&#xD;
             pressure.&#xD;
&#xD;
          -  Blood glucose level in the range of 3.9 to 5.5 mmol/L.&#xD;
&#xD;
          -  Total cholesterol level &lt; 6.0 mmol/L.&#xD;
&#xD;
          -  Triglycerides level &lt; 2.3 mmol/L.&#xD;
&#xD;
          -  No use of tobacco and no consumption of alcohol.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Suffer from chronic disease such as CVD, hypertension, diabetic, metabolic syndrome.&#xD;
&#xD;
          -  Consuming any medical prescriptions/ supplements.&#xD;
&#xD;
          -  Having blood clotting problem.&#xD;
&#xD;
          -  Women who are pregnant or lactating.&#xD;
&#xD;
          -  Hypertensive condition with systolic pressure &gt;140mmHg and diastolic pressure &gt; 90&#xD;
             mmHg.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Phooi Tee Voon, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>MPOB</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MalaysiaPOB</name>
      <address>
        <city>Kajang</city>
        <state>Selangor</state>
        <zip>43000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>November 4, 2019</study_first_submitted>
  <study_first_submitted_qc>November 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2019</study_first_posted>
  <last_update_submitted>August 31, 2020</last_update_submitted>
  <last_update_submitted_qc>August 31, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Chylomicron</keyword>
  <keyword>fatty acid composition</keyword>
  <keyword>lard</keyword>
  <keyword>palm olein</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

